Literature DB >> 12373523

Submolecular adventures of brain tyrosine: what are we searching for now?

A Kochman1, Cz Kośka, D Metodiewa.   

Abstract

This overview summarizes recent findings on the role of tyrosyl radical (TyrO(*)) in the multitudinous neurochemical systems of brain, and theorizes on the putative role of TyrO(*) in neurological disorders [Parkinson's disease (PD), Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS)]. TyrO(*) and tyrosine per se can interact with reactive oxygen species (ROS) and reactive nitrogen species (RNS) via radical mechanisms and chain propagating reactions. The concentration of TyrO(*), ROS and RNS can increase dramatically under conditions of generalized stress: oxidative, nitrative or reductive as well, and this can induce damage directly (by lipid peroxidation) or indirectly (by proteins oxidation and/or nitration), potentially causing apoptotic neuronal cell death or autoschizis. Evidence of lesion-induced neuronal oxidative stress includes the presence of protein peroxides (TyrOOH), DT (o,o'-dityrosine) and 3-NT (3-nitrotyrosine). Mechanistic details of protein- and enzymatic oxidation/nitration in vivo remain unresolved, although recent in vitro data strongly implicate free radical pathways via TyrO(*). Nitration/denitration processes can be pathological, but they also may play: 1). a signal transduction role, because nitration of tyrosine residues through TyrO(*) formation can modulate, as well the phosphorylation (tyrosine kinases activity) and/or tyrosine hydroxylation (tyrosine hydroxylase inactivation), leading to consequent dopamine synthesis failure and increased degradation of target proteins, respectively; 2). a role of "blocker" for radical-radical reactions (scavenging of NO(*), NO(*)(2) and CO(3)(*-) by TyrO(*)); 3). a role of limiting factors for peroxynitrite formation, by lowering O(2)(*-) formation, which is strongly linked to the pathogenesis of neural diseases. It is still not known if tyrosine oxidation/nitration via TyrO(*) formation is 1). a footprint of generalized stress and neuronal disorders, or 2). an important part of O(2)(*-) and NO(*) metabolism, or 3). merely a part of integral processes for maintaining of neuronal homeostasis. The full answer to these questions should be of top research priority, as the problem of increased free radical formation in brain and/or imbalance of the ratios ROS/RNS/TyrO(*) may be all important in defining whether oxidative stress is the critical determinant of tissue and neural cell injury that leads to pathological end-points.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12373523     DOI: 10.1007/s00726-001-0114-6

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  5 in total

1.  Neurotoxicological and neuroprotective elements in Parkinson's disease.

Authors:  Richard M. Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

2.  Localized tyrosine or tetrahydrobiopterin supplementation corrects the age-related decline in cutaneous vasoconstriction.

Authors:  James A Lang; Lacy A Holowatz; W Larry Kenney
Journal:  J Physiol       Date:  2010-02-22       Impact factor: 5.182

3.  Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide.

Authors:  Mahdi Goudarzvand; Mohammad Javan; Javad Mirnajafi-Zadeh; Sabah Mozafari; Taki Tiraihi
Journal:  Cell Mol Neurobiol       Date:  2009-09-19       Impact factor: 5.046

4.  Requirements for superoxide-dependent tyrosine hydroperoxide formation in peptides.

Authors:  Christine C Winterbourn; Helena N Parsons-Mair; Silvia Gebicki; Janusz M Gebicki; Michael J Davies
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

Review 5.  The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols.

Authors:  Sunisha Aryal; Taylor Skinner; Bronwyn Bridges; John T Weber
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.